Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
GATA2 links stemness to chemotherapy resistance in acute myeloid leukemia.
Journal: Blood
Published: June 17, 2024
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors.
Journal: British journal of cancer
Published: October 19, 2022
Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy.
Journal: Advances in therapy
Published: August 17, 2020
Epigenetic regulation of protein translation in KMT2A-rearranged AML.
Journal: Experimental hematology
Published: January 20, 2020
Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS).
Journal: Leukemia
Published: February 22, 2019
Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
Journal: PLoS genetics
Published: March 05, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.
Journal: Cell stem cell
Published: October 24, 2017
MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia.
Journal: Cancer cell
Published: November 20, 2016
The Functional Role of PRC2 in Early T-cell Precursor Acute Lymphoblastic Leukemia (ETP-ALL) - Mechanisms and Opportunities.
Journal: Frontiers in pediatrics
Published: April 13, 2016
The role of polycomb repressive complex 2 in early T-cell precursor acute lymphoblastic leukemia.
Journal: Molecular & cellular oncology
Published: March 10, 2016
Epigenetic modifiers in normal and malignant hematopoiesis.
Journal: Epigenomics
Published: May 06, 2015
Last Updated: 09/26/2026